The executive power of pharmaceutical investment enterprises should be highlighted

The “medicine”, an important means for pharmaceutical investment promotion, also needs detailed integration. Here is the usual "media fine investment" strategy that has always been advocated. Targeted media placement is implemented for different regions, different products, and different customer groups. In terms of product promotion and promotion, the majority of companies currently choose to distribute products through the national distribution or omni-channel distribution media, and hope to develop more customers.

However, such untargeted publicity and launching not only fails to gather resources to expand publicity for the blank investment market of pharmaceutical investment enterprises, but also poses a threat to the markets that already have fixed customers, and affects both parties' cooperation. In the pharmaceutical investment promotion, it is necessary to highlight the execution power and to implement the details; the so-called details determine the success or failure. Any improper operation of details will lead to a significant reduction in the effect of investment promotion. This requires us to be fine in every aspect of doing pharmaceutical investment.

Drugs investment promotion pointed out that no matter whether it is telemarketing skills and skills, the team to corporate image is well displayed, the details of contracting specifications, the perfection of distributors' database, the skills of pharmaceutical investment advertisements, the budget of pharmaceutical investment, the service to dealers, etc. The key links for investment promotion are indispensable. Only by ensuring the effective operation of each link and ensuring the quality of each link can we do a good job in drug investment. Pharmaceutical investment promotion companies have developed to the current resident investment promotion phase and have already had a fairly good say in the local resources and market conditions. When individual agents and businesses cannot effectively develop, it is also necessary to rely on the company’s own team to develop terminals. A good way.

Relative to the actual situation where clinical terminals are difficult to develop, companies can choose channel products that are suitable for otc, township hospitals, community clinics, and specialty hospitals to develop against these channels to ensure that pharmaceutical investment enterprise products enter the local market. After completing the development of a certain channel, the best strategy is to transfer the terminal's qualifications to local customers with certain cooperation intentions, so as to reach a deeper level of market development with the customers.

In addition to pharmaceutical investment, due to restrictions on the products, strengths, and networks of pharmaceutical investment enterprises, a considerable number of companies cannot effectively implement the excavation and development of individual agents, and may wish to change their thinking and rely on local products in areas where the products are not effectively covered. Business companies to implement regional agency development. However, it is necessary to pay attention to how to ensure the business order of these commercial companies, and delineate the business areas and channels. This will not result in the impact on other markets due to problems such as commercial distribution and allocation.